References
- Halperin JM, Newcorn JH, Matier K, Bedi G, Hall S, Sharma V. Impulsivity and the initiation of fights in children with disruptive behavior disorders. J. Child Psychol. Psychiatry36, 1199–1211 (1995).
- Sanson A, Smart D, Prior M, Oberklaid F. Precursors of hyperactivity and aggression. J. Am. Acad. Child Adolesc. Psychiatry32, 1207–1216 (1993).
- Swanson JW, Holzer CE. Violence and ECA data. Hosp. Community Psychiatry42, 954–955 (1991).
- Turgay A. Aggression and disruptive behavior disorders in children and adolescents. Expert Rev. Neurother.4(4), 623–632 (2004).
- Rivara FP, Shepherd JP, Farrington DP, Richmond PW, Cannon P. Victim as offender in youth violence. Ann. Emerg. Medicine26, 609–614 (1995).
- Nagin D, Tremblay RE. Trajectories of boys’ physical aggression, opposition, and hyperactivity on the path to physically violent and nonviolent juvenile delinquency. Child Dev.70, 1181–1196 (1999).
- Nansel TR, Overpeck M, Pilla RS, Ruan WJ, Simons-Morton B, Scheidt P. Bullying behaviors among US youth–prevalence and association with psychosocial adjustment. JAMA285, 2094–2100 (2001).
- Tremblay RE, Nagin DS, Seguin JR et al. Physical aggression during early childhood: trajectories and predictors. Pediatrics114, E43–E50 (2004).
- Keenan K, Wakschlag LS. More than the terrible twos: the nature and severity of behavior problems in clinic-referred preschool children. J. Abnorm. Child Psychol.28, 33–46 (2000).
- Nagin DS, Tremblay RE. Parental and early childhood predictors of persistent physical aggression in boys from kindergarten to high school. Arch. Gen. Psychiatry58, 389–394 (2001).
- Yudofsky SC. The Overt Aggression Scale for the objective rating of verbal and physical aggression. Am. J. Psychiatry143, 35–39 (1986).
- Kempes M, Matthys W, Maassen G, Van Goozen S, Van Engeland H. A parent questionnaire for distinguishing between reactive and proactive aggression in children. Eur. Child Adolesc. Psychiatry15, 38–45 (2006).
- Michelson D, Allen AJ, Busner J et al. Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study. Am. J. Psychiatry159, 1896–1901 (2002).
- Gibson AP, Bettinger TL, Patel NC, Crismon ML. Atomoxetine versus stimulants for treatment of attention deficit/hyperactivity disorder. Ann. Pharmacother.40(6), 1134–1142 (2006).
- Brown RT, Amler RW, Freeman WS et al. Treatment of attention-deficit/hyperactivity disorder: overview of the evidence. Pediatrics115, E749–E757 (2005).
- MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch. Gen. Psychiatry56, 1073–1086 (1999).
Website
- Mosholder A. Psychiatric adverse events in clinical trials of drugs for attention-deficit/hyperactivity disorder (ADHD). Food and Drug Administration website www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4210b_10_01_Mosholder.pdf. Accessed 28/08/06